I agree that this site is using cookies. You can find further informations here.
X
Gerds, Aaron T.
285  results:
Articles (Online) X
Search for persons X
?
1

Phase 2 study of add-on parsaclisib for patients with myelo..:

Yacoub, Abdulraheem ; Borate, Uma ; Rampal, Raajit K....
Blood Advances.  8 (2024)  6 - p. 1515-1528 , 2024
Link: https://doi.org/10.1182/..
 
?
2

Association between elevated white blood cell counts and th..:

Gerds, Aaron T. ; Mesa, Ruben ; Burke, John M....
Blood.  143 (2024)  16 - p. 1646-1655 , 2024
Link: https://doi.org/10.1182/..
 
?
3

Reduced Intensity Versus Myeloablative Allogeneic Hematopoi..:

Trunk, Andrew D. ; Chen, Yanwen ; Hamilton, Betty K....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S111-S112 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Safety and efficacy of luspatercept for the treatment of an..:

Gerds, Aaron T. ; Harrison, Claire N. ; Kiladjian, Jean-Jacques...
Blood Advances.  , 2024
Link: https://doi.org/10.1182/..
 
?
5

Real-World Use of Fedratinib for Myelofibrosis Following Pr..:

Mascarenhas, John ; Harrison, Claire ; Schuler, Tammy A....
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  2 - p. 122-132 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Reduced Intensity Versus Myeloablative Allogeneic Hematopoi..:

Trunk, Andrew D. ; Chen, Yanwen ; Gerds, Aaron T....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S111 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Momelotinib versus Continued Ruxolitinib or Best Available ..:

Harrison, Claire N. ; Vannucchi, Alessandro M. ; Recher, Christian...
Advances in Therapy.  , 2024
Link: https://doi.org/10.1007/..
 
?
8

Neighborhood Socioeconomic Disadvantage and Distance from T..:

Mian, Agrima ; Dima, Danai ; Hamilton, Betty K....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S328 , 2024
Link: https://doi.org/10.1016/..
 
?
9

A multicenter study of posttransplantation low-dose inotuzu..:

Metheny, Leland L. ; Sobecks, Ronald ; Cho, Christina...
Blood Advances.  8 (2024)  6 - p. 1384-1391 , 2024
Link: https://doi.org/10.1182/..
 
?
10

Interferons in the treatment of myeloproliferative neoplasm:

Vachhani, Pankit ; Mascarenhas, John ; Bose, Prithviraj...
Therapeutic Advances in Hematology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.1177/..
 
?
11

POSTER: MPN-383 Healthcare Resource Utilization and Costs A..:

Gerds, Aaron T. ; Tkacz, Joseph ; Moore-Schlitz, Laura...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S191 , 2023
Link: https://doi.org/10.1016/..
 
?
12

A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients w..:

Mascarenhas, John ; Migliaccio, Anna Rita ; Kosiorek, Heidi...
Clinical Cancer Research.  29 (2023)  18 - p. 3622-3632 , 2023
Link: https://doi.org/10.1158/..
 
?
13

Ten years after ruxolitinib approval for myelofibrosis: a r..:

Pemmaraju, Naveen ; Bose, Prithviraj ; Rampal, Raajit...
Leukemia & Lymphoma.  64 (2023)  6 - p. 1063-1081 , 2023
Link: https://doi.org/10.1080/..
 
?
14

P1030: SPLEEN VOLUME REDUCTION PREDICTS SURVIVAL IN MYELOFI..:

Bewersdorf, Jan ; Ajufo, Helen ; Harrison, Claire...
HemaSphere.  7 (2023)  S3 - p. e44640da , 2023
Link: https://doi.org/10.1097/..
 
?
15

Clinical outcomes of patients with myelofibrosis after imme..:

Mesa, Ruben ; Verstovsek, Srdan ; Platzbecker, Uwe...
Haematologica.  109 (2023)  2 - p. 676-681 , 2023
Link: https://doi.org/10.3324/..
 
1-15